FAT10 differentially stabilizes MYPT2 isoforms.

Human leukocyte antigen-F adjacent transcript 10 (FAT10) Isoform Myosin phosphatase (MP) Myosin phosphatase targeting subunit 2 (MYPT2) Ubiquitination

Journal

Biochemical and biophysical research communications
ISSN: 1090-2104
Titre abrégé: Biochem Biophys Res Commun
Pays: United States
ID NLM: 0372516

Informations de publication

Date de publication:
08 10 2023
Historique:
received: 01 07 2023
revised: 11 07 2023
accepted: 13 07 2023
medline: 4 9 2023
pubmed: 29 7 2023
entrez: 28 7 2023
Statut: ppublish

Résumé

Myosin phosphatase (MP) is an enzyme complex that regulates muscle contraction and plays important roles in various physiological and pathological conditions. Myosin phosphatase targeting subunit (MYPT) 2, a subunit of MP, interacts with protein phosphatase 1c to regulate its phosphatase activity. MYPT2 exists in various isoforms that differ in the composition of essential motifs that contribute to its function. However, regulatory mechanisms underlying these isoforms are poorly understood. Human leukocyte antigen-F adjacent transcript 10 (FAT10) is a ubiquitin-like modifier that not only targets proteins for proteasomal degradation but also stabilizes its interacting proteins. In this study, we investigated the effect of the interaction between FAT10 and MYPT2 isoform a (the canonical full-length form of MYPT2) or MYPT2 isoform f (the natural truncated form of MYPT2). FAT10 interacted with both MYPT2 isoforms a and f; however, only MYPT2 isoform f was increased by FAT10, whereas MYPT2 isoform a remained unaffected by FAT10. We further confirmed that, in contrast to MYPT2 isoform a, MYPT2 isoform f undergoes rapid degradation via the ubiquitin-proteasome pathway and that FAT10 stabilizes MYPT2 isoform f by inhibiting its ubiquitination. Therefore, our findings suggest that the interaction between FAT10 and MYPT2 isoforms leads to distinct stabilization effects on each isoform, potentially modulating MP activity.

Identifiants

pubmed: 37506472
pii: S0006-291X(23)00882-3
doi: 10.1016/j.bbrc.2023.07.025
pii:
doi:

Substances chimiques

Myosin-Light-Chain Phosphatase EC 3.1.3.53
Protein Isoforms 0
Protein Phosphatase 1 EC 3.1.3.16
Ubiquitin 0
Ubiquitins 0
UBD protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

115-120

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Seong Eun Song (SE)

Department of Microbiology and Immunology, Pusan National University School of Medicine, Yangsan, Republic of Korea.

Yerin Kim (Y)

Department of Microbiology and Immunology, Pusan National University School of Medicine, Yangsan, Republic of Korea.

Hoim Jeong (H)

Department of Microbiology and Immunology, Pusan National University School of Medicine, Yangsan, Republic of Korea.

Beomgu Lee (B)

Department of Microbiology and Immunology, Pusan National University School of Medicine, Yangsan, Republic of Korea.

Jihyeon Lee (J)

Department of Microbiology and Immunology, Pusan National University School of Medicine, Yangsan, Republic of Korea.

Jong Seong Roh (JS)

Department of Herbal Prescription, College of Korean Medicine, Daegu Haany University, Gyeongsan, Republic of Korea.

Min Wook So (MW)

Division of Rheumatology, Department of Internal Medicine, Pusan National University School of Medicine, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea.

Seung-Geun Lee (SG)

Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea; Division of Rheumatology, Department of Internal Medicine, Pusan National University School of Medicine, Pusan National University Hospital, Busan, Republic of Korea.

Dong Hyun Sohn (DH)

Department of Microbiology and Immunology, Pusan National University School of Medicine, Yangsan, Republic of Korea. Electronic address: dhsohn@pusan.ac.kr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH